Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said price cuts are coming for popular weight-loss drugs.
Novo Nordisk and Eli Lilly shares both fall after Novo’s price-cut plan for Ozempic and Wegovy
Related Posts
Popular News
Latest News
Harbor capital targets Anthropic, OpenAI and xAI in ‘Lab’ funds
Harbor Capital is trying to slice the AI boom into lab-branded trades, filing for a suite of active “Lab ETFs”...
A $41 Experiment Now Worth Billions
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure Nation-state adoption of Bitcoin has become the...
I’m 66 and have $85,000 in my HSA. When should I start spending it?
Most people don’t save in an HSA, so there’s little consensus on when to start drawing down the funds.
Career Advisor – LIEOC – HigherEdJobs
Company Description:Farmingdale State College is a recognized leader in applied learning. With over 10,000 students, FSC is...
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.